NASDAQ
30.12.25 | 21:52
0,730 US-Dollar
+0,73 % +0,005
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.12. | NeuroOne appoints Penumbra executive Jason Mills to board | 1 | Investing.com | ||
| 19.12. | NEUROONE MEDICAL TECHNOLOGIES Corp - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 18.12. | Neuroone Medical: EPS übertrifft Schätzungen - Umsatz besser als erwartet | 1 | Investing.com Deutsch | ||
| NEUROONE MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 17.12. | NeuroOne plans 2026 drug delivery commercialization as Q4 product revenue jumps 907% | 2 | Seeking Alpha | ||
| 17.12. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | - | SEC Filings | ||
| 05.11. | NeuroOne erhält 180-tägige Fristverlängerung zur Erfüllung der NASDAQ-Anforderungen | 5 | Investing.com Deutsch | ||
| 05.11. | NeuroOne receives 180-day extension to regain nasdaq compliance | 3 | Investing.com | ||
| 05.11. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | - | SEC Filings | ||
| 06.10. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 18.08. | NeuroOne Medical Technologies Gets Clearance From FDA For OneRF Trigeminal Nerve Ablation System | 4 | RTTNews | ||
| 18.08. | NeuroOne wins FDA nod for nerve ablation system that treats facial pain | 2 | MassDevice | ||
| 18.08. | NeuroOne Medical Technologies Corporation: NeuroOne Receives FDA 510(k) Clearance for OneRF Trigeminal Nerve Ablation System to Treat Facial Pain | 234 | GlobeNewswire (Europe) | FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical... ► Artikel lesen | |
| 14.08. | NeuroOne raises product gross margin outlook to 53% as management highlights new pain management initiatives | 5 | Seeking Alpha | ||
| 14.08. | NeuroOne übertrifft im 3. Quartal 2025 die Umsatzerwartungen | 3 | Investing.com Deutsch | ||
| 14.08. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08. | Neuroone Medical: EPS übertrifft Schätzungen um 0,02 $ - Umsatz besser als erwartet | 4 | Investing.com Deutsch | ||
| 14.08. | NeuroOne Medical Technologies GAAP EPS of -$0.03, revenue of $1.7M | 1 | Seeking Alpha | ||
| 14.08. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 14.08. | NeuroOne Medical Technologies Corporation: NeuroOne Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% | 166 | GlobeNewswire (Europe) | Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN PRAIRIE, Minn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq:... ► Artikel lesen | |
| 31.07. | NeuroOne Medical Technologies Corporation: NeuroOne to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EKSO BIONICS | 10,580 | 0,00 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,240 | +1,58 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,920 | +0,54 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| PROGYNY | 25,840 | +0,86 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,760 | +0,37 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 48,980 | +0,60 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| HEARTFLOW | 30,210 | -0,33 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,000 | -1,57 % | EILMELDUNG: Carl Zeiss Meditec-Aktie tritt auf der Stelle - Anleger warten auf das nächste Signal. | ||
| BRIGHTSPRING HEALTH SERVICES | 37,660 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 128,10 | -0,96 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| BILLIONTOONE | 85,09 | +0,69 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 26,965 | +2,02 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for... ► Artikel lesen | |
| CERIBELL | 21,710 | +1,50 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,525 | -1,94 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 27,580 | 0,00 % | Comeback 2026! Verzehnfachung möglich? Evotec, Gerresheimer, Desert Gold Aktie! | Auf der Suche nach einem möglichen Verzehnfacher im Gold-Sektor? Dies halten Analysten bei Desert Gold für möglich. Die jüngste PEA für das Flaggschiff-Gold-Projekt löst neue Kursfantasie aus. Damit... ► Artikel lesen |
NEUROONE MEDICAL TECHNOLOGIES CORPORATION gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,005 (+0,73 %) liegt der Kurs bei 0,730 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEUROONE MEDICAL TECHNOLOGIES CORPORATION finden Sie auf Wallstreet Online.